Summary
Childhood leukaemia presenting at a young age has been suspected of resulting from a leukaemogenic mutation in parental germ cells, either spontaneously or due to the exposure of a parent to leukaemogenic environmental hazards, particularly ionizing radiation. Mathematical modelling of leukaemogenesis suggests that any such patient would be especially prone to multiple independent leukaemogenic events leading to multiclonality in terms of cell of origin (analogous to bilaterality in familial retinoblastoma). To test this hypothesis we have carried out a search for multiclonal leukaemogenesis in infant and childhood acute lymphoblastic leukaemia (ALL). We used a polymerase chain reaction-based analysis of the X-linked monoamine oxidase A (MAOA) gene locus to study the clonality of marrow samples obtained from female paediatric ALL patients at the time of disease presentation. We obtained presentation samples from 102 patients of whom 72 were found to be informative at the MAOA locus. These included 20 infant leukaemias (< 1 year at diagnosis). Sixty-six samples were found to be unequivocally monoclonal while the remaining six could not, with certainty, be assigned a clonal origin. We also obtained bone marrow aspirates at first relapse as well as at presentation from eight patients. In each case the same pattern of X-linked allelic inactivation was observed at both time points of the course of the disease. No evidence was found for leukaemic multiclonality in any age group at presentation or for leukaemic ‘clone-switching’ in relapse. These findings suggest that both infant and childhood ALL is of single-cell origin and implies that leukaemic predisposition resulting from germ cell mutation is unlikely to have a major role in their pathogenesis.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allen, R. C., Zoghbi, H. Y., Mosely, A. B., Rosenblatt, H. M. & Belmont, J. W. (1992). Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51: 1229–1239.
Chessels, J. M., Eden, O. B., Bailley, C. C., Lilleyman, J. S. & Richards, S. M. (1994). Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Leukemia 8: 1275–1279.
Committee on Medical Aspects of Radiation in the Environment (COMARE). (Chairman: Prof. BA Bridges) Fourth report The Incidence of Cancer and Leukaemia in Young People in the Vicinity of the Sellafield Site, West Cumbria. Further studies and an update of the situation since the publication of the report of the Black Advisory Group in 1984, Department of Health: London
Cooper, C. S. & Stratton, M. R. (1991). Extraction and enzymatic amplification of DNA from paraffin-embedded specimens. Protocols in Human Molecular Genetics, Mathew CG (ed). pp. 133–140. The Humana Press: Clifton, NJ.
Dow, L. W., Martin, P., Moohr, J., Greenberg, M., MacDougall, L. G., Najfeld, V. & Fialkow, P. J. (1985). Evidence for clonal development of childhood acute lymphoblastic-leukaemia. Blood 66: 902–907.
Fialkow, P. J. (1976). Clonal origin of human tumours. Biochem Biophys Acta 458: 283–321.
Ford, A. M., Ridge, S., Cabrera, M. E., Mahmoud, H., Steel, C. M., Chan, L. C. & Greaves, M. (1993). In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 363: 358–360.
Gale, K. B., Ford, A. M., Repp, R., Borkhardt, A., Keller, C., Eden, O. B. & Greaves, M. F. (1997). Backtracking leukaemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94: 13950–13954.
Gardner, M. J., Snee, M. P., Hall, A. J., Powell, C. A., Downes, S. & Terrell, J. D. (1990). Results of case control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. Br Med J 300: 423–429.
Gilliland, D. G., Blanchard, K. L., Levy, J., Perrin, S. & Bunn, H. F. (1991). Clonality in myleproliferative disorders: analysis by means of the polymerase chain reaction. Proc Nat Acad Sci USA 88: 6848–6852.
Greaves, M. F. (1996). Infant leukaemia biology, aetiology and treatment. Leukemia 10: 372–377.
Greaves, M. F. & Chan, L. C. (1986). Is spontaneous mutation the major cause of childhood acute lymphoblastic leukaemia?. Br J Haematol 64: 1–13.
Griffiths, S. D., Healy, L. E., Ford, A. M., Bennett, C. A., Voncken, J. W., Heisterkamp, N., Groffen, J. & Greaves, M. F. (1992). Clonal characteristics of acute lymphoblastic cells derived from BCR/ABLp190 transgenic mice. Oncogene 7: 1391–1399.
Heisterkamp, N., Jenster, G., Ten Hoeve, J., Zovich, D., Pattengale, P. K. & Groffen, J. (1990). Acute leukaemia in bcr/abl transgenic mice. Nature 344: 251–253.
Hendriks, R. W., Chen, Z-Y, Hinds, H., Scuurman, R. K. B. & Craig, I. W. (1992). An X chromosome inactivation assay based on the differential methylation of a CpG island coupled to a VNTR polymorphism at the 5′ end of the monoamine oxidase A gene. Hum Mol Genet 1: 187–194.
Kinlen, L. J. (1993). Can paternal preconceptional radiation account for the increase in leukaemia and non-Hodgkin’s lymphoma in Seascale?. Br Med J 306: 1718–1721.
Kinzler, K. W. & Vogelstein, B. (1997). Cancer susceptibility genes: gatekeepers and caretakers. Nature 386: 761–763.
Knudson, A. G. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl & Acad Sci USA 68: 820–823.
Langdon, W. Y., Harris, A. W., Cory, S. & Adams, J. M. (1986). The c-myc oncogene perturbs lymphocyte-B development in E-mu-myc transgenic mice. Cell 1: 11–18.
Little, M. P., Charles, M. W. & Wakeford, R. (1995). A review of the risks of leukaemia in relation to parental preconception exposure to radiation. Health Phys 68: 299–310.
Lord, B., Woolford, L. B., Wang, L., Stones, V. A., McDonald, D., Lorimore, S. A., Papworth, D., Wright, E. G. & Scott, D. (1998). Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239. Br J Cancer 78: 301–311.
Mahmoud, H. H., Ridge, S. A., Behm, F. G., Pui, C-H, Ford, A. M., Raimondi, S. C. & Greaves, M. F. (1995). Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins. Med Ped Onc 24: 77–81.
Mashal, R. D., Lester, S. C. & Sklar, J. (1993). Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue. Cancer Res 53: 4676–4679.
Narod, S. A., Stiller, C. & Lenoir, G. M. (1991). An estimate of the heritable fraction of childhood cancer. Br J Cancer 63: 993–999.
Pui, C. H., Kane, J. R. & Crist, W. M. (1995). Biology and treatment of infant leukaemias. Leukemia 9: 762–769.
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, pp. 9.17–9.19. Cold Spring Harbour Laboratory Press: New York
Shu, X. O., Reaman, G. H., Lampkin, B., Sather, H. N., Pendergrass, T. W. & Robison, L. L. (1994). Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Cancer Epidemiol Biomarkers Prev 3: 645–653.
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Preisinger, A. C., Willard, H. F., Michelson, A. M., Riggs, A. D. & Orkin, S. H. (1987). Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 47: 4806–4813.
Wheldon, E. G., Lindsay, K. A. & Wheldon, T. E. (1997). A two-stage model for childhood acute lymphoblastic leukaemia: application to hereditary and non-hereditary leukaemogenesis. Math Biosci 139: 1–24.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Rinaldi, F., Mairs, R., Wheldon, T. et al. Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parents. Br J Cancer 80, 909–913 (1999). https://doi.org/10.1038/sj.bjc.6690440
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690440